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Introduction
Polyglutamine (polyQ) disorders such as Huntington’s disease 
(HD) are caused by a dominantly heritable expansion mutation 
of a triplet repeat in the coding region of the gene. The expres-
sion of this mutant protein leads to the onset of a slow, progres-
sive disorder that invariably leads to death. Thus far, neither 
an  effective treatment nor viable targets for drug design 
are available.
A prevalent feature of HD and other polyQ diseases is the 
accumulation and aggregation of the mutant protein. These 
changes lead to the formation of cytoplasmic and nuclear inclu-
sion bodies, the appearance of which indisputably signifi  es the 
inability of the cell to properly dispose of the mutant protein. 
Indeed, overexpression of expanded polyQ proteins has been 
shown to alter proteasome (Bence et al., 2001) and lysosome 
function (Qin et al., 2003). Over the past several years, animal 
models of HD (Yamamoto et al., 2000; Regulier et al., 2003; 
Harper et al., 2005) and spinocerebellar ataxia type 1 (Xia et al., 
2004; Zu et al., 2004) revealed that cells have the capacity to 
clear these products if the continuous production of the mutant 
transgene is halted. Invariably, clearance of the protein is ac-
companied by reversal of the disease-like symptoms in the 
mice. In light of these fi  ndings, it is critical to determine the 
pathway responsible for alleviating this protein accumulation to 
defi  ne targets to fi  ght these diseases.
To determine the pathway responsible for the clearance of 
mutant huntingtin (htt), we conducted a two-tiered functional 
genetic screen. We fi  rst used gene arrays to quickly assess the 
transcriptional changes induced by pathogenic polyQ lengths. 
Although these changes alone can be somewhat informative, it is 
diffi  cult to determine the functional relevance of these changes. 
Thus, we next targeted transcripts of genes that were “increased” 
with chemically synthesized small interfering RNAs (siRNAs) 
to determine which of these proteins were required for mutant 
htt clearance. Those specifi  c proteins revealed by the second 
screen then became the focus of further investigation.
Of the 56 up-regulated transcripts, 23 were required for 
mutant htt clearance. Interestingly, the pattern of genes revealed 
that activation of insulin receptor substrate 2 (IRS-2), a scaf-
folding protein that mediates the signaling cascades of growth 
factors such as insulin and insulin-like growth factor 1 (IGF-1; 
White, 2003), leads to a macroautophagy-mediated clearance of 
the accumulated polyQ proteins. Clearance is present despite 
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onditional mouse models of polyglutamine dis-
eases, such as Huntington’s disease (HD), have 
revealed that cells can clear accumulated patho-
genic proteins if the continuous production of the mu-
tant transgene is halted. Invariably, the clearance of the 
protein leads to regression of the disease symptoms in 
mice. In light of these ﬁ  ndings, it is critical to determine 
the pathway responsible for alleviating this protein ac-
cumulation to deﬁ  ne targets to ﬁ  ght these diseases. In a 
functional genetic screen of HD, we found that activation 
of insulin receptor substrate-2, which mediates the sig-
naling cascades of insulin and insulin-like growth factor 1, 
leads to a macroautophagy-mediated clearance of the 
accumulated proteins. The macroautophagy is triggered 
despite activation of Akt, mammalian target of rapamycin 
(mTOR), and S6 kinase, but still requires proteins previ-
ously implicated in macroautophagy, such as Beclin1 and 
hVps34. These ﬁ  ndings indicate that the accumulation of 
mutant protein can lead to mTOR-independent macro-
autophagy and that lysosome-mediated degradation of 
accumulated protein differs from degradation under con-
ditions of starvation.
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the activation of Akt, mammalian target of rapamycin (mTOR), 
and p70 S6 kinase. This is surprising because activation of 
mTOR is an inhibitor of the classic, starvation-induced macro-
autophagy (Meijer and Codogno, 2004). The signifi  cance of 
this is twofold: fi  rst, that macroautophagy in the presence of 
  accumulated proteins can also occur in an mTOR-independent 
manner; and second, that this represents another important 
pathway through which factors such as insulin and IGF-1 may 
exert benefi  cial effects.
Results
Clearance of accumulated proteins 
in inducible cell lines
To determine if the clearance of mutant protein can be observed 
in stable cell lines, we designed a series of functional cell-based 
assays that were similar to the HD94 mouse model (Yamamoto 
et al., 2000). Cell lines inducibly express exon1 of htt (exon1htt) 
carrying a polyQ expansion of 25, 65, or 103 residues. Induc-
ibility is conferred using the tet-off system (Gossen et al., 1994). 
To monitor the state of the proteins, and to ensure that aggregation 
was mediated primarily by the polyQ repeat, the COOH termini 
were fused to monomeric enhanced CFP (mCFP; Zacharias et al., 
2002). To ensure that our siRNA-based screen can be conducted 
as effi  ciently as possible, we fi  rst focused on HeLa-based cell 
lines (Fig. 1).  siRNA transfection effi  ciency in these cells reaches 
>80% (Elbashir et al., 2001; Pelkmans et al., 2005; unpublished 
data). To confi  rm our fi  ndings, however, we also used a neuronal 
background with Neuro2a cell lines (N2a; Fig. 9), which have 
been previously used to characterize different cellular aspects of 
HD (Wang et al., 1999; Jana et al., 2000, 2001).
The cell lines demonstrated a polyQ length–dependent 
increase of intracellular, predominantly cytoplasmic, inclusions 
(Fig. 1). After transient transfection, we observed acute, polyQ 
length–dependent cell death, as in other transiently transfected 
cell–based studies (Saudou et al., 1998; Kim et al., 1999; Waelter 
et al., 2001; Arrasate et al., 2004). After stable transfection, how-
ever, this was no longer observed across three independent cell 
lines during the duration of our experiment (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200510065/DC1). It is 
likely that the expression levels achieved were not high enough 
or that the time of expression was not long enough to elicit acute 
cell death (Jana et al., 2000). Thus, this assay is well suited to 
identify regulators of protein degradation because the absence 
of cell death will allow a clearer interpretation of the hits. None-
theless, neuronal cell death is a critical aspect of HD and other 
polyQ diseases, and therefore should always be considered when 
integrating these fi  ndings in the context of the disease.
Next, we determined if the abolition of mutant exon1htt 
expression would lead to protein clearance. Inhibition of polyQ 
expression with 100 ng/ml doxycycline (dox) led to clearance 
of both the soluble and aggregated protein (Fig. 1). Similar to 
primary cultures derived from the HD94 mice (Martin-Aparicio 
et al., 2001), within 6 d the inclusions cleared (Fig. 1 and see 
Fig. 9). Thus, both nonneuronal and neuronal cell lines are ca-
pable of clearing the mutant forms of exon1htt. These fi  ndings 
indicate that the elimination of accumulated mutant exon1htt 
is very slow. Furthermore, because the amount of time required 
for clearance is similar across cell types, including primary 
  neurons, the process underlying the elimination of this protein 
may be a general cellular event.
Continuous expression of mutant exon1 
htt leads to transcriptional changes
To identify genes that are altered because of expression of 
  mutant exon1htt, we tested our hypothesis that stable expres-
sion of 65Q or 103Q leads to transcriptional changes that re-
fl  ect   sequestration and elimination of inclusions. To examine 
Figure 1.  Stable cell lines with conditional 
expression of exon1htt-polyQmCFP. (a) Repre-
sentative images of stable cell lines with condi-
tional expression of exon1htt with 25QmCFP, 
65QmCFP, and 103QmCFP. (b) Cell  lines 
clear polyQmCFP inclusions within 6 d upon 
abolishing protein expression. Data represented 
as mean ± SEM. n = 6.IRS-2–MEDIATED CLEARANCE OF MUTANT EXON1HTT • YAMAMOTO ET AL. 721
these changes in an unbiased global manner, we determined 
the genetic profi  le of the cell lines using Affymetrix gene ar-
rays. Comparisons between exon1htt-65QmCFP (65Q) and 
 25QmCFP  clones (25Q) revealed a total of 70 transcripts in-
creased and 89 transcripts decreased. Comparisons between 
103QmCFP (103Q) and 25Q revealed 132 increased and 96 de-
creased (Fig. 2 a).  Common across both pathogenic glutamine 
lengths was the 56 increased and 42 decreased (Table S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200510065/DC1). 
  Interestingly, increases were seen in only one proteasomal 
subunit (PSMD8), but in two lysosome-associated membrane 
proteins (LAMP1 and 2). The profi  le also revealed changes in 
vesicle traffi  cking, signaling proteins, metabolic proteins, and 
hypothetical proteins.
Functional consequence of siRNA-mediated 
knockdown of transcripts revealed 
from proﬁ  ling
It is impossible to determine from profi  ling alone if the transcrip-
tional changes have any functional relevance in our pathway. 
Therefore, we used RNA interference to functionally knock-
down the transcripts that were increased in the genetic profi  le. 
Figure 2.  Two-tiered screen reveals genes that are required for the clearance of accumulated mutant exon1htt. (a) Gene proﬁ  ling identiﬁ  es transcriptional 
changes that are attributable to polyQ expression. Three Hum133A chips were run per polyQ length. For each chip, mRNA from independent clones was 
isolated to avoid clonal variability. Cluster and comparison analyses reveal that expression of pathogenic polyQ proteins leads to distinct transcriptional 
changes. The dendogram (left) is of the genes that differed from 25QmCFP samples. (b) siRNA gene knockdown reveals genes required for clearance of 
accumulated mutant exon1htt. Three to four siRNA sequences were designed and individually transfected into 65QmCFP or 103QmCFP HeLa cell lines. 
Each bar represents an individual siRNA. Cells were transfected for 48 h and then given 100 ng/ml dox for 2 d. The accumulation index is the data 
  normalized to scramble siRNA-transfected cells treated with dox. 23 genes with an accumulation index  greater than two standard deviations from 
control (designated by the gray box) were considered genes required for clearance. SiRNAs against 23 genes, including Lamp1, Lamp2, and IRS-2, lead 
to increased accumulation. Data represented as mean ± SD. Each siRNA was transfected in eight wells per experiment, and each experiment was 
repeated ﬁ  ve to eight times, as described in Materials and methods.JCB • VOLUME 172 • NUMBER 5 • 2006  722
We  reasoned that if up-regulated proteins were relevant to our path-
way, then their loss would inhibit clearance and the polyQ protein 
would continue to accumulate despite abolishing expression.
Eight EST transcripts were excluded from the siRNA 
screen. For the remaining 48 transcripts, three to four siRNA 
sequences per gene were individually transfected into two 
  different 65Q and 103Q cell lines. 48 h after transfection, cells 
were exposed to 100 ng/ml dox for another 48 h to shut down 
production of new protein and permit 50% of clearance to  occur. 
Cells were fi  xed and analyzed for the number of inclusions per 
cell using InCell Analyzer (INCA) 3000 software and calcu-
lated for an accumulation index, as described in Materials and 
methods. An example is shown in Fig. 3. 
Loss of function of 23 out of the 48 transcripts led to a 
complete or partial inhibition of clearance, of 9 led to cell death, 
and of 16 led to no change (Fig. 2). As predicted, genes involved 
in protein degradation were the most prevalent, including the 
lysosomal membrane proteins LAMP1 (Fig. 2 b, probes 3H5, 
3H6, 3H7, and 3H8) and LAMP2 (Fig. 2 b, probes A7, A8, 
A9, and A10). LAMP2 has previously been shown as essen-
tial for lysosomal function in LAMP2 knockout mice. LAMP1, 
on the other hand, was not required; however, it was surmised 
that its function was redundant to LAMP2 (Andrejewski et al., 
1999; Tanaka et al., 2000). The relatively acute loss of func-
tion offered by siRNA-mediated silencing may prevent the abil-
ity of such compensation to occur. Putative knockdown of the 
only proteasomal subunit that was altered in the gene arrays, 
PSMD8, led to cell death, and thus its role in clearance could 
not be elucidated.
IRS-2 is required for the elimination 
of mutant exon1htt aggregates
Unexpectedly, knockdown of IRS-2 led to an inhibition of 
  aggregate clearance (Figs. 2 and 3). A scaffolding protein that 
transmits the phosphatidylinositol 3-kinase (PtdIns3K) signal-
ing of growth factors like IGF-1 and cytokines, IRS-2 knockout 
mice have also revealed an important role in the brain (Schubert 
et al., 2003). Western blot analysis confi  rmed that siRNAs 
  effectively down-regulates the protein (Fig. S2, available at 
http://www.jcb.org/cgi/content/full/jcb.200510065/DC1). Fig. 3
shows representative images taken from the INCA 3000 of 
one of the two 103QmCFP clones in the absence of dox, in the 
presence of dox, and in the presence of dox after transfection 
with siRNA number 8H06, which is one of the three siRNAs 
against IRS-2. Quantifi  cation using the INCA 3000 software of 
these images shows that, after transfection of 08H06, the clear-
ance normally observed by abolishing transgene expression is 
inhibited (Fig. 3 b).
IRS-2 activation leads to enhanced 
exon1htt clearance
Because elimination of IRS-2 inhibited clearance, IRS-2 activa-
tion may stimulate clearance. Therefore, we tested a series of 
ligands known to activate IRS-2 in the following cells: insulin 
(Vassen et al., 1999), IGF-1 (Nakamura et al., 2000), and inter-
leukin-4 (IL-4; Loh et al., 1992). All three cells demonstrate 
a dose-dependent clearance of accumulated polyQ proteins 
(Fig. 4 a).  Unlike our normal clearance paradigm using dox, this 
clearance occurred despite maintaining continuous   expression of 
Figure 3.  IRS2 is required for clearance of mutant htt. (a) Representative images generated on the INCA 3000 of control (Ctrl; scramble + 2d dox), siRNA 
alone, and Dox + siIRS-2. (b) Quantiﬁ  cation of percentage of control of the number of aggregates per cell for the three images. The presence of an effective 
siRNA against IRS-2 (si8H06) abolishes the clearance seen in the presence of dox. Complete quantitative results can be found in Fig 2.IRS-2–MEDIATED CLEARANCE OF MUTANT EXON1HTT • YAMAMOTO ET AL. 723
exon1htt. As shown in Fig. 4 b, silencing IRS-2 led to a com-
plete inhibition of the enhanced clearance triggered by IGF-1. 
Western blot analysis also found that IGF-1–mediated clear-
ance is inhibited by small interfereing IRS2 (siIRS-2; Fig. S2). 
Silencing another IRS family member, IRS-1 (White, 2003), 
had no effect (Fig. 4 c and Fig. S1). Although this result is com-
pelling, we cannot completely eliminate its role because up-
  regulation of IRS-2 may mask an effect. Similar dependence 
on IRS-2, but not -1, was observed with the enhanced protein 
degradation triggered by insulin and IL-4 (unpublished data).
IRS-2–mediated clearance requires hVps34 
and Beclin 1
We next attempted to gain insight into the intracellular pathway 
by which IRS-2 activation triggers protein clearance. It has been 
previously shown that activation of IRS-2 can lead to the 
  production of PtdIns[3,4,5]phosphate by turning on the class I 
PtdIns3K (Saltiel, 2001). However, it has also been shown that 
IRS-2 phosphorylation may lead to the production of 
PtdIns[3]phosphate (PI3P; Virbasius et al., 2001; Chaussade 
et al., 2003; Maffucci et al., 2003). These latter lipid products 
are predominantly formed by a class III PtdIns3K, called hVps34 
(Schu et al., 1993; Backer, 2000).
We fi  rst determined whether the presence of PI3P leads 
to clearance. Synthetic dipalmitoyl-PI3P has been effectively 
delivered into the cell using liposomes (Franke et al., 1997; 
  Petiot et al., 2000). Administration of these liposomes to the 
exon1htt-65Q or 103QmCFP cell lines for 3 d led to a signifi  -
cant decrease in the number of inclusions per cell (Fig. 4 c and 
not depicted). Coadministration of PI3P with IGF-1 or insulin 
did not signifi  cantly enhance this effect, suggesting that they 
lie in the same pathway (unpublished data). siRNA against 
hVps34 effectively eliminated the exon1htt clearance caused
Figure 4.  IRS-2 activation leads to clearance of accumulated 
  mutant exon1htt. (a) Exon1htt-103QmCFP demonstrates a dose-
  dependent clearance of accumulated mutant protein after a 3-d 
  treatment of insulin, IGF-1, and IL-4. Expression of the exon1htt-
  polyQmCFP was maintained throughout treatment. Exon1htt-65QmCFP 
clones exhibited similar effects (not depicted). (b) Two different siRNAs 
against hVps34 signiﬁ   cantly inhibited clearance by IGF-1 
(F(2,253) = 35.576; P < 0.0001) and insulin (not depicted). Direct 
application of 10 μM dipalmitoyl-PI3P liposomes for 3 d also led to 
fewer inclusion-positive cells (F(1,30) = 28.718; P < 0.0001). Data 
represented as mean ± SEM. Asterisks indicate statistical signiﬁ  -
cance, as indicated. (c) Loss of IRS-2 (P = 0.0007) and a regulator 
of macroautophagy, Beclin1 (P < 0.0001), signiﬁ  cantly inhibited 
IGF-1–mediated clearance. siRNA-mediated silencing of IRS1 (P = 
0.3077) and Akt (P = 0.3792) had no effect (ANOVA revealed a 
signiﬁ   cant effect of siRNA on percentage of  control. F(5,186)  = 
4.907; P = 0.003). Data represented as mean ± SEM. Asterisks 
indicate statistical signiﬁ  cance, as indicated.
Figure 5.  Functional lysosomes are required for the clearance of mutant 
htt inclusions. (a) Clearance of exon1polyQhtt is inhibited in the presence 
of 1 μg/mL leupeptin (Leup), 100 nM baﬁ  lomycin A1 (Baf A1), 20 nM 
hydroxychloroquine (Chlor), 10 mM 3-methyladenine (3-MA), and 100 
nM wortmannin (Wort). All compounds inhibited the clearance usually ob-
served after 48 h dox, and thus are similar to No dox–treated cells (No 
dox). Data represented as mean ± SEM. (b) Costaining cells with 65 nM of 
Lysotracker reveals that inclusions colocalize with acidiﬁ  ed compartments.JCB • VOLUME 172 • NUMBER 5 • 2006  724
by IRS-2 activation (Fig. 4 c). Interestingly, similar to IRS-2,   
the loss of hVps34 also eliminated the clearance revealed by 
eliminating transgene expression with dox (unpublished data).
The requirement of hVps34, as well as LAMP1 and 2 
(Fig. 2), suggests that macroautophagy is being triggered. Mac-
roautophagy, which we will henceforth refer to as autophagy, is 
Figure 6.  Exon1htt-polyQmCFP htt inclusions can be found engulfed by an LC3-positive vesicle. Z-sectioned image of an Exon1htt-65QmCFP cell cotrans-
fected with eYFP-LC3. Bar, 100 μM.IRS-2–MEDIATED CLEARANCE OF MUTANT EXON1HTT • YAMAMOTO ET AL. 725
a means by which long-lived cytoplasmic proteins are degraded 
by the lysosome via engulfment and encasement by a multila-
mellar structure and fusion to the lysosome  (Klionsky and Emr, 
2000). Indeed, several studies have previously indicated that the 
induction of autophagy can lead to the clearance of aggregated 
polyQ proteins (Ravikumar et al., 2002; Iwata et al., 2005a), 
especially cytoplasmic ones (Iwata et al., 2005b). It has been 
previously shown that the inhibition of autophagy elicited by 
3-methyladenine (3-MA) is caused by the inhibition of hVps34 
(Seglen and Gordon, 1982; Blommaart et al., 1997; Petiot et al., 
2000). hVps34 acts in a multiprotein complex that includes p150 
and the mammalian orthologue of Apg6, Beclin1 (Liang et al., 
1999; Kihara et al., 2001; Tassa et al., 2003). As seen in Fig. 4 b, 
silencing of Beclin1 abolished the clearance stimulated by IRS-
2 activation. To determine if this effect is downstream of class I 
PtdIns3K activation, we next knocked down the serine/threonine 
kinase Akt. Akt is a survival kinase that was previously shown 
to be protective in several diseases, such as amyotrophic lateral 
sclerosis (ALS) and HD (Humbert et al., 2002; Kaspar et al., 
2003; Kanekura et al., 2005; Rangone et al., 2005). Although 
this siRNA against Akt effi  ciently knocks down the protein 
(Fig. S2; Jiang et al., 2003), no effect was seen on the IRS-2–
mediated clearance (Fig. 4 b). It has previously been shown that 
Akt phosphorylation of serine 421 on htt leads to fewer aggre-
gates (Humbert et al., 2002; Rangone et al., 2005). Our cell lines 
express only exon1htt, and thus this residue is not expressed. 
Perhaps monomeric htt is degraded in an Akt- and proteasome-
dependent manner. It is plausible that once an inclusion forms, 
a different method of protein degradation is required.
IRS-2 activation leads to the activation 
of autophagy
To further ascertain that IRS-2 activation potentiates autoph-
agy-mediated elimination of the accumulated protein, we exam-
ined the effect of established inhibitors of lysosomal degradation 
and macroautophagy on clearance. As shown in Fig. 5 a, lyso-
somal inhibitors inhibit the ability of the cell to eliminate the 
inclusions.  3-MA and wortmannin also eliminated clearance. 
These fi  ndings further demonstrate the importance of lysosomal 
function in exon1htt clearance and imply a role in autophagy.
Next, we examined if the inclusions colocalized with 
  autophagosomes or lysosomes. Administration of 65 nM of 
  Lysotracker, a red fl  uorescent dye that accumulates in acidic 
  organelles, showed that mCFP-positive inclusions were in acid-
ifi  ed compartments (Fig. 5 b). Using the autophagosome marker 
LC3 (Kabeya et al., 2000; Mizushima et al., 2004) and serial 
Z-sections, we found mCFP-positive inclusions surrounded by 
an LC3-positive structure (Fig. 6 and Fig. 7 a).   Although most au-
tophagosomes are known to be much smaller than the inclusion, 
under certain conditions, such as bacterial invasion, large au-
tophagosomes have been shown to occur (Nakagawa et al., 
2004). Furthermore, in a cellular model of another polyQ dis-
ease, spinal and bulbar muscular atrophy, Taylor et al. (2003) 
found polyQ inclusion bodies bound by double-membrane 
structures that were also quite large. Quantifi  cations revealed 
that  10% of the inclusion-positive cells had inclusions within 
LC3-positive vacuoles (Fig. 7 b). Consistent with the enhanced 
clearance, activation of IRS-2 using IGF-1   signifi  cantly 
  increased the frequency of colocalization. siRNA-mediated 
  silencing of IRS-2 and Beclin1 abolished this increase. Silencing 
Akt or IRS-1, again, had no effect.
Class I PtdIns3K pathway is still active 
in the mutant exon1htt cell lines
Growth factors like insulin are classic signaling molecules that 
inform the cell of the presence of nutrients. From yeast to mam-
malian cells, these factors generate PtdIns[3,4,5]phosphate. 
This leads to a signaling cascade that activates Akt, mTOR, 
Figure 7.  IRS-2 activation leads to macro-
autophagy-mediated clearance of mutant htt 
inclusions. (a) Inclusions also colocalize with 
LC3-positive autophagosomes. Treatment 
with IGF-1 leads to an increase in the fre-
quency of the colocalization of the mCFP-posi-
tive inclusions, whereas knockdown of Beclin1 
eliminates this colocalization. (b) Quantiﬁ  ca-
tion of the percentage of inclusions found in 
LC3-  positive autophagosomes. Administration 
of IGF-1 leads to an increased frequency of 
colocalization versus control. P < 0.0001. 
Loss of Akt had no effect on this outcome. 
P = 0.0003. Loss of IRS-2 (P = 0.3232) and 
Beclin1 (P = 0.4281) eliminated this increase. 
(ANOVA revealed a signiﬁ  cant effect of siRNA 
(F(3,24) = 4.183; P = 0.0161) and treatment 
(F(1,24) = 29.151; P < 0.0001) on the percent-
age of cells with LC3-positive inclusions. There 
was also a signiﬁ  cant interaction between siRNA 
and treatment (F(3,24) = 6.524; P = 0.0022). 
Data represented as mean ± SEM. Asterisks 
  indicate statistical signiﬁ  cance, as indicated.JCB • VOLUME 172 • NUMBER 5 • 2006  726
and the translation activator p70S6K (Jacinto and Hall, 2003). 
A known consequence of this pathway is an inhibition of mac-
roautophagy, which is a catabolic process. This is contrary to 
our results, in which the same receptor activates degradation 
of mutant exon1htt inclusions by autophagy. To ensure that our 
fi  ndings are not caused by a disturbance of normal signaling 
processes, we reexamined the effect of insulin and IGF-1 on 
both the proper phosphorylation of known downstream kinases 
and on autophagy caused by amino acid deprivation.
Whole cell lysates were collected from 65QmCFP- or 
103QmCFP-expressing cells after exposure to IGF-1 or insu-
lin for 30 min (Fig. 8 b).  Phosphospecifi  c antibodies against 
Akt and p70S6K revealed that, indeed, the targets were rapidly 
activated in these clones. Therefore, we concluded that the clas-
sical autophagic response is intact in our cell lines. Recent work 
by Scott et al. (2004), however, found that long-term activation 
of p70S6K can also induce autophagy. To ensure that mTOR 
signaling is intact in the cell lines, phosphospecifi  c antibodies 
Figure 8.  Macroautophagy caused by amino acid withdrawal is un-
changed in mutant exon1htt-polyQ cell lines. (a) In the presence of mutant 
exon1htt expression, Akt and p70S6 kinase (S6K) are phosphorylated 
upon stimulation with IGF-1 and Ins for 30 min. In the presence of 
mutant exon1, mTOR is phosphorylated and decreases after amino acid 
withdrawal (-aa; 4 h) or 20 nM rapamycin (1 h). IGF-1 and Ins inhibit 
the effect of amino acid withdrawal. (b) [
14C]valine-labeled long-lived 
protein degradation in response to 4 h amino acid withdrawal. ANOVA 
revealed a signiﬁ  cant effect of treatment on the percentage of proteoly-
sis (F(5,19) = 7.160; P = 0.0006). 10 μM PI3P-containing liposomes 
also increased proteolysis in the presence of full serum, as previously 
shown (P = 0.0010). 100 nM Ins (P = 0.8763) and 10 nM IGF-1 
(P = 0.3999) inhibited the enhanced proteolysis caused by amino acid 
withdrawal (P = 0.0016), as did 10 mM 3-MA (P = 0.3074). Data 
  represented as mean ± SEM.
Figure 9.  IRS-2 activation-mediated autophagy in a conditional neuronal 
cell line. (a) N2a stable cell lines inducibly expressing exon1htt-25QmCFP 
and -103QmCFP. Nuclei are stained with Hoechst 33342. (b) Clearance 
of accumulated protein occurred in 6 d. Data represented as mean ± SEM. 
(c) IRS-2 and Beclin 1 are required for IGF-1–mediated clearance. ANOVA 
revealed a signiﬁ  cant effect across groups (F(4,43) = 5.793; P = 0.0008) 
Fisher’s protected least signiﬁ  cant difference test for “%Control” revealed a 
signiﬁ  cant difference between control and dox-treated cells (P = 0.0006) 
and control and IGF-1–treated cells (P = 0.0179). Coadministration of 
siRNA against beclin1 (P = 0.9611) or IRS-2 (P = 0.4712) with IGF-1 
eliminated clearance. Data represented as mean ± SEM. Asterisks indi-
cate statistical signiﬁ  cance, as indicated. (d) Quantiﬁ  cation of the mCFP-
positive inclusions found in LC3-positive autophagosomes. ANOVA 
revealed a signiﬁ  cant effect across group (F(3,16) = 3.873; P = 0.0294). 
Fisher’s protected least signiﬁ   cant difference test for “% cells with LC3-
  positive inclusions” revealed a signiﬁ  cant difference between control and 
IGF1 (P = 0.0097), but no difference with siIRS-2 (P = 0.7881) or siBeclin1 
(P = 0.8372). Data represented as mean ± SEM. Asterisks indicate statistical 
signiﬁ  cance, as indicated.IRS-2–MEDIATED CLEARANCE OF MUTANT EXON1HTT • YAMAMOTO ET AL. 727
against mTOR were also used. Phosphorylated mTOR was read-
ily detectable in the presence of mutant exon1htt expression, as 
well as in the presence or absence of mutant htt expression (Fig. 
8 a and not depicted). Amino acid deprivation and rapamycin 
decreased mTOR phosphorylation in these cells, whereas in-
sulin and IGF-1 inhibited the effect of amino acid withdrawal. 
Thus, the IGF-1 and insulin lead to the predictive phosphoryla-
tion of p70S6K and mTOR.
We next examined proteolysis of long-lived proteins. Prote-
olysis was measured by [
14C]valine-labeled long-lived proteins. 
103QmCFP cell lines were under dox suppression for 2 wk to 
ensure no transgene expression because the presence of these 
proteins led to high levels of baseline protein degradation, de-
spite the presence of full serum. Insulin and IGF-1 signifi  cantly 
attenuated the amount of proteolysis, whereas PI3P induced pro-
teolysis despite the presence of complete media. Furthermore, 
the administration of 3-MA also diminished degradation (Fig. 8 b). 
Thus, the autophagy- mediated clearance of inclusions by IGF-1 
and Ins occurs despite proper signaling by mTOR.
IRS-2 activates autophagy in inducible 
neuronal mutant exon1htt cell lines
IRS-2 is expressed in all insulin-responsive organs, including 
the brain. We examined if IRS-2 could activate macroautophagy 
in response to protein accumulation in neuronal cell lines (Fig. 9).  
Similar to the HeLa cells, elimination of novel polyQ protein 
production led to clearance over a period of 6 d. We stimulated 
IRS-2 using IGF-1 to determine if a similar mechanism was at 
play. IRS-2 activation using IGF-1 also led to an autophagy-
mediated clearance of polyQ proteins in cells of a neuronal 
  lineage. The clearance was accompanied by an increased colo-
calization of mCFP-positive inclusions in YFP-LC3 autophago-
somes. Again, knockdown of Beclin1 inhibited the colocalization 
of inclusions in the autophagosomes.
Discussion
Using a unique two-tiered functional genetic screen, this study 
revealed an unexpected means by which autophagy-mediated 
clearance of accumulated mutant protein can be activated. 
We found that the activation of IRS-2 led to macroautophagy-
induced clearance of the accumulated polyQ proteins (Fig. 10).   
The activation was dependent on class III PtdIns3K activation 
and occurred despite activation of Akt, mTOR, and p70S6K.
These fi  ndings highlight several points. The fi  rst is that 
activation of IRS-2 can lead to the clearance of accumulated 
mutant exon1htt. IRS-2 is widely expressed and, together with 
IRS-1, mediates the signaling of insulin and IGF-1 in most 
tissue (Sun et al., 1992, 1995). White (2003) found that loss 
of IRS-2 function in knockout mice led to an accumulation of 
neurofi  brillary tangles containing phosphorylated tau in the 
  absence of changes in the kinase glycogen synthase kinase 3β. 
In light of our fi  ndings, it is possible that the loss of IRS-2 
exposed a potential role for these proteins to mediate clearance 
of these complex proteins. It would be interesting to determine 
if protein accumulation is occurring in other tissues that are 
IRS-2 defi  cient.
Activators of IRS-2, such as insulin and IGF-1, have both 
been shown to strongly promote neuronal survival through 
stimulation of Akt. Consequently, its effi  cacy has been tested 
as such in other neurodegenerative diseases, such as ALS. 
For example, retroviral delivery of IGF-1 in a mouse model of 
Figure 10.  Working model of IRS-2-mediated activation 
of autophagy. IRS-2 activation leads to the formation 
of PI3P via hVps34. Beclin1 and hVps34 allow for the 
  autophagosomes to form and engulf the aggregates. 
As other studies indicate (gray box) aggregate forma-
tion alone may trigger autophagy via a yet unknown 
  pathway, but mTOR inhibition or p70S6 kinase activation 
(Scott et al., 2004) may play a role.JCB • VOLUME 172 • NUMBER 5 • 2006  728
ALS led to amelioration of the phenotype, together with a dimin-
ishing of the accumulated mutant SOD1 (Kaspar et al., 2003). 
A placebo-controlled trial in American ALS patients found that 
the progression of functional impairment signifi  cantly slowed 
in the treated patients, with no adverse side effects (Lai et al., 
1997). The outcome suggested an IGF-1 dose-dependent treat-
ment effect. For HD, Humbert et al. (2002) have examined the 
neuroprotective effect of Akt stimulation by transiently trans-
fecting mutant htt into primary neurons. Similar to the fi  ndings 
in ALS, they found that IGF-1 administration led to both a de-
crease in the number of aggregates formed and a decrease in 
cell death. The mechanism through which IGF-1 elicited both 
effects was believed to be directly downstream of Akt (Rangone 
et al., 2004, 2005). We were able to determine that the autopha-
gocytic clearance can also occur independent of Akt because 
its knockdown did not eliminate clearance. Monomeric and ag-
gregated proteins may be degraded differently. These fi  ndings 
indicate that the protection conferred by the insulin signaling 
pathway in diseases with protein accumulation may be twofold; 
the classical neuroprotective pathway triggered by Akt and the 
enhanced clearance stimulated by hVps34 activation. Because 
cytoplasmic inclusions are more readily degraded by autoph-
agy, it is now critical to determine to what extent these inclu-
sions contribute to pathology.
Another point highlighted by this study is that macro-
autophagy is indeed capable of degrading large inclusions and 
is stimulated under conditions previously deemed inhibitory. 
Activation of IRS-2 in the HeLa cell lines was achieved by us-
ing insulin, IGF-1, or IL-4. Signaling through these receptors, 
however, is also known to inhibit mTOR-mediated autophagy 
through the activation of class I PtdIns3K and mTOR. Nonethe-
less, there is evidence that autophagy may occur despite mTOR 
activation. For example, transgenic expression of the autophago-
somal marker LC3 demonstrates that in certain tissue autopha-
gosomes constitutively form, even in the absence of starvation 
(Mizushima et al., 2004). Consistent with these fi  ndings, immor-
talized cells of certain lineages also have a higher basal activity 
of macroautophagy (Mizushima, 2004). More recently, Iwata 
et al. (2005a) found that proteasome inhibition was a potent acti-
vator of autophagy, although the role of mTOR in the response 
was not explored. In this study, our fi  ndings indicate that 
  macroautophagy is the mechanism by which the aggregates are 
cleared, despite mTOR activation. This could be achieved if the 
autophagy regulators downstream of mTOR, such as hVps34, 
could be activated. Therefore, the activity observed in our   results 
may represent a competition between the inhibitory effects of 
activating class I versus III kinases. Moreover, Scott et al. (2004) 
clearly demonstrated in the Drosophila melanogaster fat body 
that the regulation of autophagy may occur differently from 
what was previously believed. They found that constitutive 
activation of p70S6K was indeed required for autophagy, rather 
than inhibitory as previously described (Klionsky et al., 2005). 
The presence of expanded polyQ proteins may offset the balance 
between p70S6K and mTOR, thus, allowing for IRS-2 activation 
to perpetuate a signal to drive autophagy.
Another possibility is that inclusion formation itself trig-
gers autophagy (Taylor et al., 2003) in an mTOR-dependent 
fashion, and IRS-2 activation perpetuates this response down-
stream of mTOR regulation. Indeed, a previous study showed 
that inclusions can sequester mTOR and, thus, could activate 
autophagy (Ravikumar et al., 2004). However, in our cell lines, 
we did not fi  nd mTOR sequestration. Nonetheless, differentia-
tion between mTOR dependence and independence is diffi  cult 
because the activation of IRS-2 is upstream of both the inhibi-
tory and stimulatory signaling. To test this hypothesis, we must 
fi  rst understand how mTOR negatively regulates autophagy in 
mammalian cells. This is not yet fully defi  ned. In yeast, TOR 
has been shown to negatively regulate the activation of the 
Apg13–Apg1 complex, a kinase required for autophagy, but 
it is not certain if this is attributable to direct phosphorylation 
by TOR (Kamada et al., 2000). Furthermore, in mammalian 
cells, the orthologues of neither Apg13 nor Apg1 have yet to 
be   identifi   ed. mTOR-dependent autophagy has mainly been 
confi  rmed in mammalian systems through the use of chemical 
  inhibitors such as rapamycin. Chemical compounds that directly 
activate mTOR are not available.
In conclusion, by starting with a nonhypothesis-driven ap-
proach, we were able to discover that the regulation underlying 
degradation of accumulated proteins differs from the regulation 
underlying conditions of starvation. Furthermore, this work dem-
onstrates that we can no longer assume that regulatory mecha-
nisms studied under nonpathogenic conditions are static; cells 
compensate when confronted with toxic conditions. Accordingly, 
we have found that the insulin-signaling pathway may be an im-
portant avenue through which this might be achieved. Indeed, 
activation of IRS-2 has been an attractive target for the treatment 
of type II diabetes, and thus this line of research may also benefi  t 
other disorders. In any case, it is clear from these studies that 
more information regarding the importance of lysosomal degra-
dation pathways such as autophagy in neuronal systems is abso-
lutely crucial. Controlling these pathways that degrade mutant htt 
will allow us to fi  nally begin to treat this terrible disease.
Materials and methods
Materials
N2a cells were purchased from American Type Culture Collection. Insulin, 
IGF-1, IL-4, and dox were purchased from Sigma-Aldrich. Antibodies were 
purchased from Upstate Biotechnology (anti–IRS-2, anti–phospho Akt, and 
anti–phospho S6 kinase), BD Biosciences (Akt, S6 kinase, and IRS-1), Cell 
Signaling Technology (anti–phospho-mTOR and anti-mTOR), and Roche 
(anti-GFP). htt-exon1 (CAGCAA) constructs were obtained from A. Kazant-
sev (Massachusets General Hospital, Charlestown, MA). pYFP-LC3 was 
obtained from T. Yoshimori (National Institute of Genetics, Mishima, 
  Shizuoka, Japan).
Creation of cell line
N2a were selected to be tTA-positive by transfection with PCMV-tTA-IRES-neo 
and selection with 800 μg/ml G418. PolyQ cell lines were created by 
  cotransfecting Hela and N2a with tetO-htt (25Q, 65Q, or 103Q) exon1-
mCFP and PTk-hygro (CLONTECH Laboratories, Inc.) and then selected with 
hygromycin using 800 and 200 μg/ml, respectively. 100 ng/ml dox was 
also maintained in the culture media during selection to maintain suppres-
sion of transgene expression. HeLa cells were maintained in DME with 
10% FCS, whereas N2a cells were maintained in 50% DME/50% 
  Optimem in 10% FCS.
RNA preparation and gene arrays
Cells were plated in a 100-mm dish, harvested using 100 μL TRIzol 
reagent (Invitrogen) and isolated per the manufacturer’s instructions. IRS-2–MEDIATED CLEARANCE OF MUTANT EXON1HTT • YAMAMOTO ET AL. 729
RNA was resuspended and further puriﬁ  ed using the RNAeasy kit (QIA-
GEN). RNA was labeled and hybridized onto human U133A chips at the 
Genome Core Facility at Memorial Sloan Kettering Cancer Center (MSKCC). 
Array results were analyzed using GeneSpring 2.0 (Agilent Technologies) and 
an Affymetrix software package 5.0.
Transfection
siRNAs were designed using an algorithm designed by Jagla et al. (2005). 
siRNA were created at either Integrated DNA Technologies or the Func-
tional Proteonomics Project at MSKCC. Scramble siRNA sequences were pur-
chased from Dharmacon. A ﬁ  nal concentration of 10 or 20 nM of siRNAs 
was used for silencing. Cells were transfected using OligofectAMINE per 
the manufacturer’s instructions. 7.5 × 10
3 cells were plated in 96-well 
ViewPlates (Packard Instrument Co.) and transfected the next day. 48 h af-
ter transfection, cells were split across two wells and treated with dox. Cells 
were examined 48 h later. Transfection of plasmid DNA was accomplished 
using LipofectAMINE per the manufacturer’s instructions. Compounds were 
administered 48 h after transfection unless otherwise noted.
Image analysis with the INCA 3000 
For the high throughput screen, images were collected on the INCA 3000 
(GE Healthcare). Cells in 96-well ViewPlates were ﬁ  xed for 10 min with 4% 
PFA, and the nuclei were stained using 1 μM Hoechst 333342 for 30 min. 
After scanning the plates, images were analyzed using the granularity analy-
sis module on the accompanying software. In brief, the granularity analysis 
quantiﬁ  es the number of inclusions (grains) within a cell, using a two-color 
strategy to identify individual cells and to analyze associated grains. After 
recognizing the objects, in this case the Hoechst-positive nuclei, the algo-
rithm next identiﬁ  es, using a speciﬁ  ed size range (in pixels) and ﬂ  uorescent 
intensity gradient, the grain in the proximity of the object. Both the Ngrains 
(number of qualifying grains per cell) and the fraction of ﬂ  uorescent within 
the qualifying grains gave similar results. To calculate the accumulation in-
dex used in Fig. 2, values were ﬁ  rst normalized as a percentage of control 
for scramble siRNA–transfected cells treated with 2 d of 100 ng/ml dox, 
and set to 0 by subtracting 100%. This would permit comparison across 
all of the experiments conducted and a quick assessment of the direction of 
the change—an increase in accumulation (>0) or an increase in clearance 
(<0). A gene was considered required for clearance when the absolute 
value of accumulation index was greater than two standard deviations of 
the Scramble siRNA + 2 d dox. Each siRNA was transfected on 8 wells 
per 96-well plate, and each experiment was repeated ﬁ  ve to eight times. 
Cell viability was determined through several measures. First, we examined 
the number of cells per well scanned. If a drug or siRNA led to signiﬁ  cantly 
fewer cells, they were initially considered toxic. If this toxicity consistently ap-
peared across experiments, we next conﬁ  rmed toxicity using an inclusion/
exclusion assay of cell death, known as a LIVE/DEAD assay (Invitrogen).
Other image analysis
Cells were grown on glass (HeLa) or poly-D-lysine–coated (N2a) 
coverslips in 24-well plates. Cells were ﬁ  xed for 10 min with 4% PFA. 
Nuclei were stained with Hoechst 33342 for 30 min, and membranes 
were stained using Alexa Fluor 633–labeled cholera toxin subunit B ob-
tained from Invitrogen. Images were acquired using a confocal microscope 
(TCS SP2; Leica) at 63× magniﬁ  cation, along with the accompanying soft-
ware package. Data acquisition was performed using National Institutes of 
Health Image 4.0. Analysis of variance (ANOVA) and post hoc analyses 
were conducted using Statview 5.0 (SAS Institute, Inc.).
PI3P liposomes
Synthetic dipalymitoyl-PI3Ps (Matreya) were dried together with phosphati-
dylserine at a 1:1 concentration under argon and vacuum and resus-
pended in 25 mM Hepes, 100 mM KCl, and 1 mM EDTA to a total lipid 
concentration of 800 μM. Liposomes were freeze-thawed, then manually 
extruded through two 50-nm polycarbonate membranes. PI3P/phosphati-
dylserine liposomes were administered to cells at 20 μM for 3 d, ﬁ  xed, 
and assessed for clearance.
Measuring degradation of long-lived proteins in response 
to amino acid deprivation
This protocol was adapted from previously reported protocols (Talloczy 
et al., 2002; Scarlatti et al., 2004). Cells were incubated for 18 h at 37°C 
with 0.5 μCi/ml L-[
14C]valine–supplemented media. Cells were rinsed with 
HBSS to remove unincorporated radioisotopes and then chased in fresh 
media overnight to allow degradation of short-lived proteins. Cells were 
rinsed in HBSS + 10 mM Hepes and incubated for 4 h with either 
full media ± rapamycin, 20 mM PI3P liposomes, or HBSS + 10 mM 
Hepes ± 3-MA,20 μM PI3P liposomes, 100 nM insulin, or 100 nM IGF-1. 
Cells were scraped and, using TCA, protein was precipitated from both the 
incubation media and the cells. Proteolysis was assessed as the acid-soluble 
radioactivity divided by the radioactivity maintained in the precipitate.
Online supplemental material
Fig. S1 shows cell lines that were monitored for cell death using the 
LIVE/DEAD assay. Fig. S2 shows whole cell lysates from transfected cells 
that were run on SDS-PAGE gels, transferred to PVDF membranes, and 
probed with the antibodies as noted. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200510065/DC1.
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